IN8BIO, INC. — Investor Relations & Filings
IN8BIO, INC. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. The company's proprietary DeltEx™ platform utilizes allogeneic, autologous, and genetically modified approaches to develop novel cell therapies. IN8BIO was the first to advance genetically modified gamma-delta T cells into clinical trials. Its lead product candidates include INB-400, a Phase 2 asset for newly diagnosed glioblastoma (GBM), and INB-100, a Phase 1 candidate for patients with leukemia undergoing hematopoietic stem cell transplantation. The company is also advancing a broad portfolio of preclinical programs focused on solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3/A | 2026-05-18 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46474546 | S-3/A | 2026-05-18 | English | ||
| 43589305 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589284 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589220 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589208 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589206 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43596317 | S-8 - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43518284 | 8-K - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 33052209 | ARS - IN8BIO, INC. (0001740279) (Filer) | 2026-03-26 | English | ||
| 32897569 | 8-K - IN8BIO, INC. (0001740279) (Filer) | 2026-02-27 | English | ||
| 31546757 | 8-K Filing | 2026-02-09 | English | ||
| 31546837 | 4 Filing | 2026-02-06 | English | ||
| 31546738 | 4 Filing | 2026-02-06 | English | ||
| 31546677 | 4 Filing | 2026-02-06 | English | ||
| 31546594 | 4 Filing | 2026-02-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
IN8BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35200/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35200 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35200 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35200 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35200}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IN8BIO, INC. (id: 35200)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.